(Q70390827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

10 October 2019

main subject

1 reference

A Sochalski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

S Sullman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

V T Andriole

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

0 references

publication date

1 May 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Surgery

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

5A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

96-101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

The comparative in-vitro activity of cefotetan against anaerobic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

Activity of cefotetan against anaerobic bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

Cefotetan pharmacokinetics in volunteers with various degrees of renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

Pharmacokinetics of cefotetan (YM09330) in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

Role of the infectious disease specialist in containing costs of antibiotics in the hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980222-8

10.1016/S0002-9610(88)80222-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132048%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference